NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-69 Cr | ₹-136 Cr | ₹38 Cr | ₹-114 Cr | ₹-5.48 Cr |
What is the latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-69 Cr |
Mar2023 | ₹-136 Cr |
Mar2022 | ₹38 Cr |
Mar2021 | ₹-114 Cr |
Mar2020 | ₹-5.48 Cr |
How is Cash Flow from Financing Activities of NEULAND LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-69 Cr | Negative | |
Mar2023 | ₹-136 Cr | Negative | |
Mar2022 | ₹38 Cr | Positive | |
Mar2021 | ₹-114 Cr | Negative | |
Mar2020 | ₹-5.48 Cr | - |
Compare Cash Flow from Financing Activities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹15,063.6 Cr | -19.8% | -13.8% | 90.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,939.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
CIPLA | ₹117,835.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,784.6 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹90,722.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -19.8% |
-13.8% |
90.3% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses